Chattem To Revive Rolaids Line Bought From J&J
This article was originally published in The Tan Sheet
Executive Summary
Chattem snaps up Rolaids from Johnson & Johnson subsidiary McNeil, which never restocked the iconic heartburn relief brand after recalling and suspending production in 2010. Sanofi touts Rolaids as “an enduring brand with a deep heritage.”
You may also be interested in...
Nexium OTC Switch Would Face Crowded Field, Potential Questions
Pfizer will pay AstraZeneca $250 million upfront for global rights to market a potential OTC 20-mg Nexium. Pharma marketing expert Joe McGovern expects Nexium “to start OTC with a big bang,” but Center for Consumer Self Care Executive Director Bill Soller points to potential safety questions about a switch.
Ilex Revitalizes Di-gel And St. Joseph Aspirin Lines Before Relaunching
Ilex Consumer Products Group plans to make its mark in the consumer health care products arena by relaunching and “revitalizing iconic American brands,” including the recently acquired di-gel digestive relief brand and St. Joseph Aspirin.
FDA Enforces Consent Decree Over J&J/McNeil's OTC Manufacturing
FDA will wield tight oversight of Johnson & Johnson subsidiary McNeil Consumer Healthcare's OTC manufacturing operations under a consent decree filed after the firm's quality-control changes failed to satisfy the agency.